Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00531037 · ClinicalTrials.gov registry record
Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers
A clinical trial of Patients Implanted With a Pacemaker, sponsored by LivaNova.
- Completed
- Registry status
- 1,440
- Enrollment target
- 20
- Study locations
NCT00531037: Completed study of Patients Implanted With a Pacemaker, sponsored by LivaNova.
NCT00531037 is a study of Patients Implanted With a Pacemaker that has completed, run by LivaNova. The registered enrollment target is 1,440 participants. The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00531037, a study of Patients Implanted With a Pacemaker, has completed, sponsored by LivaNova.
- COMPLETED
- Registry status
- 1,440 participants
- Enrollment target
- 20
- Study locations
Study Summary
Observational study to assess AV block incidence and their evolution according to paroxysmal atrial arrhythmia.
Conditions Studied
Study Locations (20)
Other
- Az St- Blasius - Dendermonde
- Ch de Huy - Huy
- Heilig Hart Ziekenhuis MOL - Mol
- Hospital Hamilton - Hamilton
- Niagara Health System - Niagara
- Bispebjerg Hospital - Bispebjerg
- HELLERUP - Gentofte Hospital
- Clinique Esquirol - Agen
- CH Albi - Albi
- Clinique Claude Bernard - Albi
- CH ALES - Alès
- Clinique Bonnefond - Alès
- Cabinet Prive - Annecy
Alabama
- Baptist Princeton Birmingham - Birmingham
- Tennessee Valley Sheffield - Sheffield
Arizona
- Cardiovascular Assoc. Of Mesa - Mesa
California
- O'Connor Hospital San Jose - San Jose
Georgia
- Piedmont hospital - Piedmont
Mississippi
- University of Mississippi Medical Center - Mississippi City
Oklahoma
- St. Francis Hospital Tulsa - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,440 participants |
| Start Date | 2007-06 |
| Est. Completion | 2011-12 |
What the finished NCT00531037 record still lists
NCT00531037 is an observational study that tracks outcomes without assigning an intervention. Its 1,440 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Patients Implanted With a Pacemaker appearing as the primary indexed condition, and to 0 interventions.
NCT00531037 names 20 study sites across 7 states, led by Other, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00531037 about?
NCT00531037 is a clinical study titled "Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers". Observational study to assess AV block incidence and their evolution according to paroxysmal atrial arrhythmia.
What is the current status of trial NCT00531037?
This trial is currently completed. The enrollment target is 1,440 participants. The study started on 2007-06. Estimated completion is 2011-12.
What conditions does trial NCT00531037 study?
This clinical trial studies the following conditions: Patients Implanted With a Pacemaker.
Who is sponsoring clinical trial NCT00531037?
This trial is sponsored by LivaNova, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00531037 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Georgia, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
- NCT04989790 · 1,440 participants · NA
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
- NCT06122246 · 1,440 participants · NA
PRESSURE CHECK: Find Your Path to Better Health
- NCT06324318 · 1,440 participants · Phase 2
Parenting in 2 Worlds Multisite Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia